1. Home
  2. COLB vs TGTX Comparison

COLB vs TGTX Comparison

Compare COLB & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Banking System Inc.

COLB

Columbia Banking System Inc.

HOLD

Current Price

$30.79

Market Cap

9.2B

Sector

Finance

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$54.64

Market Cap

7.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLB
TGTX
Founded
1993
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
7.9B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
COLB
TGTX
Price
$30.79
$54.64
Analyst Decision
Hold
Strong Buy
Analyst Count
14
5
Target Price
$31.46
$49.80
AVG Volume (30 Days)
3.1M
2.2M
Earning Date
04-23-2026
05-04-2026
Dividend Yield
5.08%
N/A
EPS Growth
N/A
1746.67
EPS
1.38
0.17
Revenue
$177,000,000.00
$2,785,000.00
Revenue This Year
$31.52
$49.08
Revenue Next Year
$2.90
$26.69
P/E Ratio
$22.35
$297.41
Revenue Growth
18.94
N/A
52 Week Low
$23.83
$26.76
52 Week High
$33.68
$59.30

Technical Indicators

Market Signals
Indicator
COLB
TGTX
Relative Strength Index (RSI) 41.13 59.92
Support Level $30.78 $51.22
Resistance Level $31.11 $58.08
Average True Range (ATR) 0.59 2.10
MACD -0.11 0.39
Stochastic Oscillator 8.11 80.70

Price Performance

Historical Comparison
COLB
TGTX

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Share on Social Networks: